Dosis peligrosas: una historia real de policías, falsificadores y la contaminación del suministro de medicamentos de Estados Unidos

What is Dangerous Doses about?

Dangerous Doses is an investigative journalistic work that exposes how a network of criminals managed to infiltrate the US pharmaceutical supply chain, introducing counterfeit and contaminated medicines. The author, Katherine Eban, meticulously reconstructs the counterfeiters' operations, the authorities' response, and the impact on patients. The book combines the pace of a thriller with the rigor of an investigative report, revealing the flaws in a system that should protect public health.

Why is it a must-read?

The work documents real cases of theft, adulteration, and illegal sales of drugs, showing how the pursuit of profit can endanger people's lives. Eban interviewed undercover agents, pharmaceutical executives, and victims, offering a unique perspective on a problem affecting millions. The book has been praised for its ability to make a complex topic accessible and for the depth of its investigation. It is essential reading for health professionals, pharmacy students, and anyone interested in medication safety.

What do readers think?

Those who have read Dangerous Doses highlight the meticulousness with which Eban unravels a web of corruption and greed. They point out that the book is a wake-up call about the hidden dangers in the drug supply chain. Comments emphasize that, although the reading can be disturbing, it is necessary to understand the magnitude of the problem. Many recommend it not only to specialists but to any consumer who wants to be informed about the risks they face when purchasing drugs.

Frequently Asked Questions

Does the book contain technical information?

Yes, but it is explained clearly and accessibly, without requiring prior knowledge of the pharmaceutical industry. The author balances precise data with a captivating narrative.

Is it suitable for pharmacy students?

Absolutely. Many students and professionals consider it a valuable tool for understanding the reality of the drug market and the importance of traceability.

Does it only deal with the United States?

Although the focus is on the US, the lessons about the vulnerability of supply chains are applicable globally, which makes it relevant to readers in other countries.